Identification of HLA-A*01- and HLA-A*02-restricted CD8+ T-cell epitopes shared among group B enteroviruses

Journal of General Virology

Volumn 89, Issue 9, 2008, Pages 2090-2097

  Weinzierl, Andreas O ^a   Rudolf, Despina ^a   Maurer, Dominik ^a   Wernet, Dorothee ^a   Rammensee, Hans Georg ^a   Stevanović, Stefan ^a   Klingel, Karin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A1 ANTIGEN; HLA A2 ANTIGEN; VIRUS PROTEIN; HLA A ANTIGEN; HLA A*01 ANTIGEN, HUMAN; HLA A*02 ANTIGEN; HLA-A*01 ANTIGEN, HUMAN; HLA-A*02 ANTIGEN;

ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; ENTEROVIRUS; GENETIC VARIABILITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCREENING; VIRUS IDENTIFICATION; AMINO ACID SEQUENCE; CHRONIC DISEASE; COXSACKIE VIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; ENTEROVIRUS INFECTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MYOCARDITIS; PATHOGENICITY; PROTEIN PROCESSING;

ENTEROVIRUS;

AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COXSACKIEVIRUS INFECTIONS; CROSS REACTIONS; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; HLA-A ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; MYOCARDITIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 52649088192     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.2008/000711-0     Document Type: Article

References (30)

1. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H,. McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. & Davis, M. M. (1996). Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96.
2. Baboonian, C., Davies, M. J., Booth, J. C. & McKenna, W. J. (1997). Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol 223, 31-52.
3. Boucek M. M., Faro, A., Novick, R. J., Bennett, L. E., Keck B. M. & Hosenpud, J. D. (2001). The registry of the international society for heart and lung transplantation: fourth official pediatric report-2000. J Heart Lung Transplant 20, 39-52.
4. Bouslama, L., Nasri, D., Chollet, L., Beiguith, K., Bourlet, T., Aouni, M., Pozzetto, B. & Pillet, S. (2007). Natural recombination event within the capsid genomic region leading to a chimeric strain of human enterovirus B. J Virol 81, 8944-8952.
5. + T lymphocytes by structural and functional assays. Cancer Immunol Immunother 57, 289-302.
6. Chua, B. H., McMinn, P. C., Lam, S. K. & Chua, K. B. (2001). Comparison of the complete nucleotide sequences of echovirus 7 strain UMMC and the prototype (Wallace) strain demonstrates significant genetic drift over time. J Gen Virol 82, 2629-2639.
7. Codd, M. B., Sugrue, D. D., Gersh, B. J. & Melton, L. J., III (1989). Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation 80, 564-572.
8. Coulie, P. G., Karanikas, V., Colau, D., Lurquin, C., Landry, C., Marchand, M., Dorval, T., Brichard, V. & Boon, T. (2001). A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci U S A 98, 10290-10295.
9. Hermans, I. F., Silk, J. D., Yang, J., Palmowski, M. J., Gileadi, U., McCarthy, C., Salio, M., Ronchese, F. & Cerundolo, V. (2004). The VITAL assay: a versatile fluorometric technique for assessing CTL-and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J Immunol Methods 285, 25-40.
10. + T cells in lymphoid and peripheral sites of coxsackievirus B3 infection. J Virol 82, 4331-4342.
11. Khetsuriani, N. (2006). Lamonte-Fowlkes, A., Oberst, S., Pallansch, M. A.; Centers for Disease Control and Prevention. Enterovirus surveillance-United States, 1970-2005. MMWR Surveill Summ 55, 1-20.
12. Kim, K. S., Hufnagel, G., Chapman, N. M. & Tracy, S. (2001). The group B coxsackieviruses and myocarditis. Rev Med Virol 11, 355-368.
13. Klingel, K., Schnorr, J. J., Sauter, M., Szalay, G. & Kandolf, R. (2003). β2-microglobulin-associated regulation of interferon-γ and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. Am J Pathol 162, 1709-1720.
14. Klingel, K., Sauter, M., Bock, C. T., Szalay, G., Schnorr, J. J. & Kandolf, R. (2004). Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol 193, 101-107.
15. Knowlton, K. U. & Badorff, C. (1999). The immune system in viral myocarditis: maintaining the balance. Circ Res 85, 559-561.
16. McManus, B. M., Chow, L. H., Radio, S. J., Tracy, S. M., Beck, M. A., Chapman, N. M., Klingel, K. & Kandolf, R. (1991). Progress and challenges in the pathological diagnosis of myocarditis. Eur Heart J 12 (Suppl. D), 18-21.
17. Modlin, J. F. & Rotbart, H. A. (1997). Group B coxsackie disease in children. Curr Top Microbiol Immunol 223, 53-80.
18. Opavsky, M. A., Penninger, J., Aitken, K., Wen, W. H., Dawood, F., Mak, T. & Liu, P. (1999). Susceptibility to myocarditis is dependent on the response of αβ T lymphocytes to coxsackieviral infection. Circ Res 85, 551-558.
19. Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A. & Stevanovic, S. (1999). SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219.
20. Rotbart, H. A. (1995). Enteroviral infections of the central nervous system. Clin Infect Dis 20, 971-981.
21. Rotbart, H. A., McCracken, G. H., Jr, Whitley, R. J., Modlin, J. F., Cascino, M., Shah, S. & Blum, D. (1999). Clinical significance of enteroviruses in serious summer febrile illnesses of children. Pediatr Infect Dis J 18, 869-874.
22. Saeed, M., Zaidi, S. Z., Naeem, A., Masroor, M., Sharif, S., Shaukat, S., Angez, M. & Khan, A. (2007). Epidemiology and clinical findings associated with enteroviral acute flaccid paralysis in Pakistan. BMC Infect Dis 7, 6.
23. Schirle, M., Keilholz, W., Weber, B., Gouttefangeas, C., Dumrese, T., Becker, H. D., Stevanovic, S. & Rammensee, H. G. (2000). Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach. Eur J Immunol 30, 2216-2225.
24. Schmitz, M., Wehner, R., Stevanovic, S., Kiessling, A., Rieger, M. A., Temme, A., Bachmann, M., Rieber, E. P. & Weigle, B. (2007). Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11. Cancer Lett 245, 331-336.
25. Simmonds, P. & Welch, J. (2006). Frequency and dynamics of recombination within different species of human enteroviruses. J Virol 80, 483-493.
26. + T cells during picornavirus infection. J Virol 75, 2377-2387.
27. Stanway, G., Brown, F., Christian, P., Hovi, T., Hyypiä, T., King, A. M. Q., Knowles, N. J., Lemon, S. M., Minor, P. D. & other authors (2005). Family Picornaviridae. In Virus Taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses, pp. 757-778. Edited by C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger & L. A. Ball. London: Elsevier/Academic Press.
28. Strikas, R. A., Anderson, L. J. & Parker, R. A. (1986). Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J Infect Dis 153, 346-351.
29. Varela-Calvino, R., Skowera, A., Arif, S. & Peakman, M. (2004). Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein. J Virol 78, 13399-13408.
30. + donors. Eur J Immunol 35, 2876-2885.